189 related articles for article (PubMed ID: 33188076)
1. Position-Dependent Differential Targeting of Somatic Hypermutation.
Zhou JQ; Kleinstein SH
J Immunol; 2020 Dec; 205(12):3468-3479. PubMed ID: 33188076
[TBL] [Abstract][Full Text] [Related]
2. A Model of Somatic Hypermutation Targeting in Mice Based on High-Throughput Ig Sequencing Data.
Cui A; Di Niro R; Vander Heiden JA; Briggs AW; Adams K; Gilbert T; O'Connor KC; Vigneault F; Shlomchik MJ; Kleinstein SH
J Immunol; 2016 Nov; 197(9):3566-3574. PubMed ID: 27707999
[TBL] [Abstract][Full Text] [Related]
3. Interpretable deep learning reveals the role of an E-box motif in suppressing somatic hypermutation of AGCT motifs within human immunoglobulin variable regions.
Tambe A; MacCarthy T; Pavri R
Front Immunol; 2024; 15():1407470. PubMed ID: 38863710
[TBL] [Abstract][Full Text] [Related]
4. Recombinase-mediated cassette exchange as a novel method to study somatic hypermutation in Ramos cells.
Baughn LB; Kalis SL; MacCarthy T; Wei L; Fan M; Bergman A; Scharff MD
mBio; 2011; 2(5):. PubMed ID: 21990614
[TBL] [Abstract][Full Text] [Related]
5. Analysis of 6912 unselected somatic hypermutations in human VDJ rearrangements reveals lack of strand specificity and correlation between phase II substitution rates and distance to the nearest 3' activation-induced cytidine deaminase target.
Ohm-Laursen L; Barington T
J Immunol; 2007 Apr; 178(7):4322-34. PubMed ID: 17371989
[TBL] [Abstract][Full Text] [Related]
6. Complex regulation of somatic hypermutation by cis-acting sequences in the endogenous IgH gene in hybridoma cells.
Ronai D; Iglesias-Ussel MD; Fan M; Shulman MJ; Scharff MD
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11829-34. PubMed ID: 16087866
[TBL] [Abstract][Full Text] [Related]
7. A critical context-dependent role for E boxes in the targeting of somatic hypermutation.
McDonald JJ; Alinikula J; Buerstedde JM; Schatz DG
J Immunol; 2013 Aug; 191(4):1556-66. PubMed ID: 23836058
[TBL] [Abstract][Full Text] [Related]
8. Sequence intrinsic somatic mutation mechanisms contribute to affinity maturation of VRC01-class HIV-1 broadly neutralizing antibodies.
Hwang JK; Wang C; Du Z; Meyers RM; Kepler TB; Neuberg D; Kwong PD; Mascola JR; Joyce MG; Bonsignori M; Haynes BF; Yeap LS; Alt FW
Proc Natl Acad Sci U S A; 2017 Aug; 114(32):8614-8619. PubMed ID: 28747530
[TBL] [Abstract][Full Text] [Related]
9. Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences.
Yang SY; Fugmann SD; Schatz DG
J Exp Med; 2006 Dec; 203(13):2919-28. PubMed ID: 17178919
[TBL] [Abstract][Full Text] [Related]
10. Models of somatic hypermutation targeting and substitution based on synonymous mutations from high-throughput immunoglobulin sequencing data.
Yaari G; Vander Heiden JA; Uduman M; Gadala-Maria D; Gupta N; Stern JN; O'Connor KC; Hafler DA; Laserson U; Vigneault F; Kleinstein SH
Front Immunol; 2013; 4():358. PubMed ID: 24298272
[TBL] [Abstract][Full Text] [Related]
11. Mutating for Good: DNA Damage Responses During Somatic Hypermutation.
Pilzecker B; Jacobs H
Front Immunol; 2019; 10():438. PubMed ID: 30915081
[TBL] [Abstract][Full Text] [Related]
12. Characterization of DNA G-Quadruplex Structures in Human Immunoglobulin Heavy Variable (IGHV) Genes.
Tang C; MacCarthy T
Front Immunol; 2021; 12():671944. PubMed ID: 34040612
[TBL] [Abstract][Full Text] [Related]
13. Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation.
Scherer F; Navarrete MA; Bertinetti-Lapatki C; Boehm J; Schmitt-Graeff A; Veelken H
Leuk Lymphoma; 2016; 57(1):151-60. PubMed ID: 25860234
[TBL] [Abstract][Full Text] [Related]
14. Sex-Biased Aging Effects on Ig Somatic Hypermutation Targeting.
Cui A; Chawla DG; Kleinstein SH
J Immunol; 2021 Jan; 206(1):101-108. PubMed ID: 33288546
[TBL] [Abstract][Full Text] [Related]
15. Ongoing somatic hypermutation of the rearranged VH but not of the V-lambda gene in EBV-transformed rheumatoid factor-producing lymphoblastoid cell line.
Chezar I; Lobel-Lavi L; Steinitz M; Laskov R
Mol Immunol; 2008 Nov; 46(1):80-90. PubMed ID: 18718665
[TBL] [Abstract][Full Text] [Related]
16. Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting.
Longo NS; Lugar PL; Yavuz S; Zhang W; Krijger PH; Russ DE; Jima DD; Dave SS; Grammer AC; Lipsky PE
Blood; 2009 Apr; 113(16):3706-15. PubMed ID: 19023113
[TBL] [Abstract][Full Text] [Related]
17. The IgH
Martin OA; Thomas M; Marquet M; Bruzeau C; Garot A; Brousse M; Bender S; Carrion C; Choi JE; Vuong BQ; Gearhart PJ; Maul RW; Le Noir S; Pinaud E
Front Immunol; 2023; 14():1030813. PubMed ID: 36865553
[TBL] [Abstract][Full Text] [Related]
18. The IgH 3' regulatory region controls somatic hypermutation in germinal center B cells.
Rouaud P; Vincent-Fabert C; Saintamand A; Fiancette R; Marquet M; Robert I; Reina-San-Martin B; Pinaud E; Cogné M; Denizot Y
J Exp Med; 2013 Jul; 210(8):1501-7. PubMed ID: 23825188
[TBL] [Abstract][Full Text] [Related]
19. The absence of DNA polymerase kappa does not affect somatic hypermutation of the mouse immunoglobulin heavy chain gene.
Shimizu T; Shinkai Y; Ogi T; Ohmori H; Azuma T
Immunol Lett; 2003 May; 86(3):265-70. PubMed ID: 12706529
[TBL] [Abstract][Full Text] [Related]
20. Beyond Hot Spots: Biases in Antibody Somatic Hypermutation and Implications for Vaccine Design.
Schramm CA; Douek DC
Front Immunol; 2018; 9():1876. PubMed ID: 30154794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
